Sinopharm Group Co Ltd buy jomobb
.jpg?locale=us "jomobb")
Start price
16.05.21
/
80%
€2.72
Target price
16.05.22
€3.60
Performance (%)
-28.13%
End price
29.01.22
€1.96
Summary
This prediction ended on 29.01.22 with a price of €1.96. The price of Sinopharm Group Co Ltd has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.13%. jomobb has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sinopharm Group Co Ltd | 0.459% | 0.459% | -24.688% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% |
According to jomobb what are the pros and cons of Sinopharm Group Co Ltd for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Standard Investments for future growth
Strong uniques
Growths faster than the competition
Market Leader or Top 3
Future proof or reliable business model
Cons
Significant cyclical dependencies
Comments by jomobb for this prediction
In the thread Sinopharm Group Co Ltd diskutieren
Die Fundamentaldaten sind überzeugend, auch ohne Covid -19 Sonderkonjunktur.